important new developments in these arenas in the past decade.
Sequencing, particularly the use of multilocus sequenced typing and the creation of a multilocus sequenced typing database, has also been a key development in understanding the epidemiology of human Campylobacter infection. In particular, these subtyping efforts are increasingly used to attribute the human health burden to specific sources. Further refinement of these source attribution techniques are urgently needed for the consideration of possible intervention strategies by policy makers.
Although the third edition is a comprehensive compendium, there are a few omissions. Campylobacter causes human infection worldwide. Therefore, perhaps the most important omission in the third edition is the absence of an updated chapter on human Campylobacter infection in the developing world. Because the burden of human illness from Campylobacter infection may be remarkable different between the developed and developing world, discussing the epidemiology of human Campylobacter infection in developing countries would be useful. Furthermore, the paucity of contributors from regions other than Europe, North America, Japan, Australia, and New Zealand illustrates a need for the Campylobacter scientific community to improve capacity building efforts and mentoring of scientists from these missing areas.
The first edition, Campylobacter jejuni: Current status and Future Trends, was published in 1992 and, although its 300 pages were focused on C. jejuni, is widely viewed as a landmark publication in the field. Interestingly, in the foreword to the second edition of Campylobacter, published in 2000, the editors boldly proclaimed their confidence that the second edition would become an "equally authoritative and valuable source of information" as the first edition. In the 8 years since publication of the second edition, most researchers involved in Campylobacter work likely agree that the prediction of the editors has been fulfilled. The third edition, with its remarkable new materials and outstanding updates likely will also be judged in the years to come as an equally authoritative and valuable source.
There have been impressive scientific advances in the understanding of clinical aspects, epidemiology, and pathogenesis of Campylobacter during the past 2 decades. These advances, which are described well in the third edition, provide a strong foundation on which it is now necessary for the research community to develop practical interventions to prevent human infection; the third edition of Campylobacter is an essential resource for these public health efforts. The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the Department of the Army, the Department of Defense, or the US government.
an emphasis on the period inclusive of World War II. This well-referenced and easy-to-follow book addresses many of the basic and complex malaria-related challenges facing the United States before and during World War II. The US antimalarial program eventually screened 114,000 compounds, thoroughly evaluated the prewar antimalarial agent atabrine, and after the war tested a therapeutic and chemoprophylactic agent, chloroquine, that would become the backbone of malaria management for decades. In addition to the program's direct goal of improving the management of malaria, the broader and possibly more-lasting influence of the program was to function as a template for large-scale disease-based biomedical research. As is well outlined by Slater, this program brought together diverse research organizations-including government laboratories, universities, and pharmaceutical and chemical companies-to perform clinical and basic science studies.
After providing a thorough introductory chapter, Slater uses 8 subsequent chapters to address various aspects of malaria research. He briefly summarizes the impact of major advances in malaria research, including the identification of the etiological agent along with its life cycle, environment, and ecology. He also highlights the history of the production of quinine (the reliable antimalarial therapeutic agent that was widely used at the onset of World War II) along with the effect of Japan's control of Java-the primary source of the drug-during the war. Furthermore, he raises insightful issues pertaining to malaria before World War II that are still relevant to clinicians today, including the distribution of antimicrobials, drug toxicity profiles, governmental approval of medications, industry involvement in promoting drugs, lawsuits, costs, and the lack of drug development for patient populations that bear the burden of disease. In addition, he stresses the role played by adequate animal models in drug development. He describes Germany's robust drug-development program, which arose during the growth of the country's substantial chemical industry, as it relates to antimalarial therapy. His description of the establishment of specific goals for the US antimalarial program and how the work of the Rockefeller Foundation was built upon sets the stage for the cooperation and coordination between the government, academia, and industry, ensuring a militarily relevant product. As the program grew, it became overburdened with increased bureaucracy, transitioning from coordination to administration. He also highlights the individual personalities involved and the various ethical conflicts associated with increased governmental involvement, legal contracts, and proprietary issues. The seventh chapter focuses on chloroquine, which was abandoned by the German drug company Bayer because of the results of animal toxicity studies conducted before the war. The US interest in chloroquine was heightened after a German prisoner of war was captured with another 4-aminoquinoline, sontochin.
The final chapter is probably the most impactful for today's researchers because of the various lessons learned from the US antimalarial program. Slater outlines how many of the strategies and personnel were directly linked to future programs or forbearers of future programs in the US government and military. More interesting is his insightful comments on the continued concern over malaria care 150 years after World War II. Despite the recent advances of new drug therapies, improved diagnostics, the possibility of a vaccine, and vast support (such as that from the Bill and Melinda Gates Foundation, the World Health Organization, and the US government, including the President's Malaria Initiative [$1.2 billion over 5 years] instituted in 2005 by the then president George W. Bush), there are still scores of people dying of malaria daily. Given the ongoing issue of malaria as well as human immunodeficiency virus infection, tuberculosis, and extensively drug-resistant bacteria, the knowledge gained from the development and growth of the US antimalarial program should assist in addressing the medical issues of today to ensure that the lessons of history are remembered. In conclusion, I think that War and Disease is a well-written book that provides insight into the US antimalarial program of the 20th century and into the subsequent research programs that are attempting to deal with the challenging diseases of today. 
